Zobrazeno 1 - 10
of 128
pro vyhledávání: '"PANTAZIDES, A."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pantazides, Brooke G., Quiñones-González, Jennifer, Rivera Nazario, Danisha M., Crow, Brian S., Perez, Jonas W., Blake, Thomas A., Johnson, Rudolph C.
Publikováno v:
In Journal of Chromatography B 15 July 2019 1121:9-17
Autor:
den Herder, Jan-Willem A., Nikzad, Shouleh, Nakazawa, Kazuhiro, Minami, Takahiro, Nagawsawa, Shunsaku, Zhang, Yixian, Cooper, Kristopher, Pantazides, Athanasios, Glesener, Lindsay, Kanniainen, Hunter, Watanabe, Shin, Narukage, Noriyuki, Takahashi, Tadayuki
Publikováno v:
Proceedings of SPIE; August 2024, Vol. 13093 Issue: 1 p130932A-130932A-11, 12962280p
Autor:
Boles, Stephanie L, Pantazides, Brooke G, Perez, Jonas W, Sternberg, Maya R, Crow, Brian S, Blake, Thomas A
Publikováno v:
Journal of Applied Laboratory Medicine; Mar2024, Vol. 9 Issue 2, p342-349, 8p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
David S. Yu, Shishir K. Maithel, Jerome C. Landry, Walter J. Curran, N. Volkan Adsay, Charles A. Staley, Bassel F. El-Rayes, David A. Kooby, Jeanne Kowalski, Rini Pauly, Khanjan Gandhi, Joseph W. Shelton, William A. Hall, Burcu Saka, Elaine A. Liu, Ganji P. Nagaraju, Yunfeng Pan, Matthew D. Warren, Claire W. Hardy, Matthew Z. Madden, Brooke G. Pantazides, Sarah B. Fisher, Aleksandra V. Petrova, Lauren E. Colbert
PDF file - 981KB, Representative Immunohistochemistry for CHD7 Expression in Primary Tumor Tissue (S1). Network Analysis via MetaCore ExPlain Process Network Analysis for genes involved in CHK1, CDC25A, AURKB, PLK1, HUS1 pathway (S2). CHD7 Knockdown
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f687cfb63a40d8f7b46cfc59f873e38
https://doi.org/10.1158/0008-5472.22400186.v1
https://doi.org/10.1158/0008-5472.22400186.v1
Autor:
David S. Yu, Shishir K. Maithel, Jerome C. Landry, Walter J. Curran, N. Volkan Adsay, Charles A. Staley, Bassel F. El-Rayes, David A. Kooby, Jeanne Kowalski, Rini Pauly, Khanjan Gandhi, Joseph W. Shelton, William A. Hall, Burcu Saka, Elaine A. Liu, Ganji P. Nagaraju, Yunfeng Pan, Matthew D. Warren, Claire W. Hardy, Matthew Z. Madden, Brooke G. Pantazides, Sarah B. Fisher, Aleksandra V. Petrova, Lauren E. Colbert
PDF file - 70KB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f267719353b9e36e54de770f98e4812
https://doi.org/10.1158/0008-5472.22400189.v1
https://doi.org/10.1158/0008-5472.22400189.v1
Autor:
David S. Yu, Shishir K. Maithel, Jerome C. Landry, Walter J. Curran, N. Volkan Adsay, Charles A. Staley, Bassel F. El-Rayes, David A. Kooby, Jeanne Kowalski, Rini Pauly, Khanjan Gandhi, Joseph W. Shelton, William A. Hall, Burcu Saka, Elaine A. Liu, Ganji P. Nagaraju, Yunfeng Pan, Matthew D. Warren, Claire W. Hardy, Matthew Z. Madden, Brooke G. Pantazides, Sarah B. Fisher, Aleksandra V. Petrova, Lauren E. Colbert
XLS file - 675KB, Full Results of Primary Gemcitabine Sensitivity Screen (S1). Known DNA Damage Response Genes Identified as Hits in Gemcitabine Sensitivity Screen (S2). Dysregulation, Differential Expression, and Literature RNAi Cross-Reference for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::220f0f9ca0da0a47d9c2bf9e8c49c2c2
https://doi.org/10.1158/0008-5472.22400183.v1
https://doi.org/10.1158/0008-5472.22400183.v1
Autor:
David S. Yu, Shishir K. Maithel, Jerome C. Landry, Walter J. Curran, N. Volkan Adsay, Charles A. Staley, Bassel F. El-Rayes, David A. Kooby, Jeanne Kowalski, Rini Pauly, Khanjan Gandhi, Joseph W. Shelton, William A. Hall, Burcu Saka, Elaine A. Liu, Ganji P. Nagaraju, Yunfeng Pan, Matthew D. Warren, Claire W. Hardy, Matthew Z. Madden, Brooke G. Pantazides, Sarah B. Fisher, Aleksandra V. Petrova, Lauren E. Colbert
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with poor outcomes with current therapies. Gemcitabine is the primary adjuvant drug used clinically, but its effectiveness is limited. In this study, our objective was to use a rational
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::be303e40f2df248b6537491cf49645b7
https://doi.org/10.1158/0008-5472.c.6505520
https://doi.org/10.1158/0008-5472.c.6505520
Autor:
Pantazides, Brooke G.1 (AUTHOR), Crow, Brian S.1 (AUTHOR) jgz8@cdc.gov, Quiñones-González, Jennifer1,2 (AUTHOR), Perez, Jonas W.1 (AUTHOR), Harvilchuck, Jill A.3 (AUTHOR), Wallery, Jeffrey J.3 (AUTHOR), Hu, Tom C.4 (AUTHOR), Thomas, Jerry D.1 (AUTHOR), Johnson, Rudolph C.1 (AUTHOR), Blake, Thomas A.1 (AUTHOR)
Publikováno v:
Analytical & Bioanalytical Chemistry. Mar2021, Vol. 413 Issue 6, p1765-1776. 12p.